SII Investments’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,832
Closed -$215K 356
2017
Q4
$215K Sell
1,832
-29,980
-94% -$3.39M 0.02% 352
2017
Q3
$3.61M Sell
31,812
-2,970
-9% -$343K 0.21% 100
2017
Q2
$4.34M Buy
34,782
+525
+2% +$62.2K 0.27% 79
2017
Q1
$4.06M Buy
34,257
+81
+0.2% +$9.18K 0.28% 79
2016
Q4
$3.42M Buy
34,176
+11,960
+54% +$1.28M 0.26% 90
2016
Q3
$2.81M Buy
22,216
+182
+0.8% +$22.5K 0.22% 94
2016
Q2
$2.57M Buy
22,034
+88
+0.4% +$9.96K 0.21% 101
2016
Q1
$2.28M Buy
21,946
+2,133
+11% +$206K 0.21% 94
2015
Q4
$1.97M Sell
19,813
-3,144
-14% -$308K 0.25% 88
2015
Q3
$2.09M Sell
22,957
-5,291
-19% -$530K 0.24% 97
2015
Q2
$3M Sell
28,248
-3,167
-10% -$350K 0.35% 69
2015
Q1
$3.58M Sell
31,415
-148
-0.5% -$16.9K 0.43% 55
2014
Q4
$3.48M Sell
31,563
-2,457
-7% -$259K 0.46% 54
2014
Q3
$3.33M Buy
34,020
+1,650
+5% +$162K 0.45% 60
2014
Q2
$3.26M Buy
32,370
+1,792
+6% +$175K 0.47% 58
2014
Q1
$2.75M Sell
30,578
-135
-0.4% -$12.4K 0.51% 55
2013
Q4
$2.77M Buy
30,713
+497
+2% +$43K 0.49% 54
2013
Q3
$2.41M Sell
30,216
-107
-0.4% -$8.42K 0.57% 48
2013
Q2
$2.21M Buy
+30,323
New +$2.27M 0.48% 52

Other funds holding ZBH

SII Investments's ZBH Position: Q1 2018 in Review

SII Investments sold out of Zimmer Biomet (ZBH) in Q1 2018, closing a stake of 1,832 shares — an estimated $215K sold.

SII Investments first reported a position in ZBH in Q2 2013 and held it in 19 quarters. The position peaked at $4.34M in Q2 2017. 875 funds tracked by Wall St. Rank hold ZBH as of Q1 2018.

  • SII Investments reported no remaining Zimmer Biomet position as of Q1 2018 after selling out during the quarter.
  • SII Investments sold 1,832 Zimmer Biomet shares in Q1 2018, an estimated $215K.
  • SII Investments first reported a position in Zimmer Biomet in Q2 2013 and held it in 19 quarters.
  • SII Investments's Zimmer Biomet position peaked at $4.34M in Q2 2017.
  • 875 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2018.

Based on SII Investments's 13F filing for Q1 2018.